FOGHORN THERAPEUTICS INC's ticker is FHTX and the CUSIP is 344174107. A total of 46 filers reported holding FOGHORN THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,737,610 | +42.0% | 3,147,522 | +100.0% | 1.72% | -39.7% |
| Q2 2023 | $11,079,277 | +41.7% | 1,573,761 | +24.8% | 2.85% | -58.5% |
| Q1 2023 | $7,819,818 | -2.8% | 1,261,261 | 0.0% | 6.86% | -8.9% |
| Q4 2022 | $8,046,845 | -25.6% | 1,261,261 | 0.0% | 7.53% | -25.1% |
| Q3 2022 | $10,822,000 | -36.9% | 1,261,261 | 0.0% | 10.05% | -31.1% |
| Q2 2022 | $17,153,000 | -10.7% | 1,261,261 | 0.0% | 14.59% | +30.7% |
| Q1 2022 | $19,209,000 | -33.4% | 1,261,261 | 0.0% | 11.16% | -31.9% |
| Q4 2021 | $28,845,000 | +64.2% | 1,261,261 | 0.0% | 16.40% | +92.0% |
| Q3 2021 | $17,569,000 | +30.5% | 1,261,261 | 0.0% | 8.54% | +95.5% |
| Q2 2021 | $13,458,000 | -19.0% | 1,261,261 | 0.0% | 4.37% | -21.5% |
| Q1 2021 | $16,623,000 | -35.0% | 1,261,261 | 0.0% | 5.56% | +2.8% |
| Q4 2020 | $25,566,000 | – | 1,261,261 | – | 5.41% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Capital LLC | 1,261,261 | $25,566,000 | 5.41% |
| Flagship Pioneering Inc. | 12,674,120 | $256,905,000 | 4.68% |
| Birchview Capital, LP | 314,143 | $6,368,000 | 3.67% |
| Monashee Investment Management LLC | 560,360 | $11,359,000 | 1.50% |
| Artal Group S.A. | 1,720,720 | $34,879,000 | 0.75% |
| Alphabet Inc. | 500,901 | $10,153,000 | 0.49% |
| Cormorant Asset Management, LP | 1,000,000 | $20,270,000 | 0.48% |
| Casdin Capital, LLC | 216,216 | $4,383,000 | 0.13% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 258,700 | $5,244,000 | 0.08% |
| Woodline Partners LP | 103,040 | $2,089,000 | 0.06% |